Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer

Background/Objectives: Photoimmunotherapy (PIT) is an innovative approach for the targeted therapy of cancer. In PIT, photosensitizer dyes are conjugated to tumor-specific antibodies for targeted delivery into cancer cells. Upon irradiation with visible light, the photosensitizer dye is activated an...

Full description

Bibliographic Details

Published in:	Antibodies
Main Authors:	Isis Wolf, Susanne Schultze-Seemann, Christian Gratzke, Philipp Wolf
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Subjects:	prostate cancer photoimmunotherapy CD44 EpCAM antibody dye conjugates
Online Access:	https://www.mdpi.com/2073-4468/14/1/5